MLTX
MoonLake ImmunotherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
Current thesis
Composite grade D from latest DB weights. Momentum 55.3 / Value 41.1
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +19.9.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
55
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $27.77
Why
Momentum55 · Δ7d +19.9
Value41 · Δ7d +0.0
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
55
52% active weight
Current posture
7d trendImproving
Δ7d
+19.9
Δ21d
+32.6
Value
41
48% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 55.3 / Value 41.1
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$1.32B
Beta
1.20
Shares Out
71.9M
P/E (TTM) · Derived
-5.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-6.22
Rev YoY
-
EPS YoY
-95.6%
Gross Margin
-
Op Margin
-
Net Debt
-$448.03M
Current Ratio
8.50
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology